| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213729 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 31 Pages |
Abstract
IMRT after chemotherapy can provide excellent dose conformity and achieve favorable survival and LRC with mild toxicities in patients with early-stage WR-DLBCL. Dose constraints for the parotid glands should be limited to <24Â Gy for early-stage WR-DLBCL.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yong-Gang MD, Shu-Nan MD, Shu-Lian MD, Yue-Ping MD, Wei-Hu MD, Jing MD, Yong-Wen MD, Hua MD, Hui MD, Xiao-Hui MD, Mei MD, Bo MD, Ning-Ning MD, Ning MD, Yuan MD, Yu MD, Jian-Rong PhD, Ye-Xiong MD,